Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SuperStitch may have potential in PFOs (patent foramen ovale):

This article was originally published in Clinica

Executive Summary

SuperStitch EL, the suturing device developed by Sutura (Fountain Valley, California) has been used successfully in early studies to close a patent foramen ovale (PFO), raising the possibility that its indications could be expanded. Currently available in the EU and US for vascular stitching in general surgery, the device has now been shown to be capable of suturing shut a PFO in an explanted porcine heart in two trials, one conducted in London, UK, and another in California. Sutura's chairman and CSO, Dr Anthony Nobles, said that human testing would provide further data.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT049293

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel